Mayor tells Seymour that it was only when directors were made personally liable that any material differences were made

Let’s start with a story about the wild power of confirmation bias in the world of psychedelics. A story about magic mushrooms, dementia and research ethics.

This article examines the operations of what Trouillot named the “Savage slot” in psychedelic science. Indigenous efforts to break out of the “Savage …

Rationale: A reliable and valid instrument is needed to measure exposure to psychedelic-related media to examine the impact of media and expectations on outcomes in psychedelic clinical trials. Object...

Abstract This article establishes a conceptual framework for decolonial drug histories and, at the same time, moves beyond decolonization. It brings back the radical alterity of historical figures of ...

A large international panel of experts reach consensus on a new standard for reporting settings in psychedelic trials, identifying 30 key non-pharmacological factors to strengthen the rigor of psyched...

A new study critiques how Western psychology has stripped psychedelics of their communal and transformative potential, turning them into marketable, individualistic treatments.

Objective This article outlines recommendations from 30 psychedelic researchers on how to create a better psychedelic safety net. Methods A survey of 30 psychedelic researchers asked them to ident...

The Swiss psychedelic medicine programme considers some patients' complaints

A decade before Airbnb persuaded homeowners to transform their homes into hotels, Netflix convinced its users to turn theirs into mini Netflix warehouses. Customers who held onto their DVDs for longer...

As we come to the end of another year, we’re kicking off our Year in Review with a look back at some of our top articles from 2024.

Institute for Biomedical Ethics